Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected] Learn more

anti-FX(a) Emi HC
(Plasmid #113665)

Ordering

Item Catalog # Description Quantity Price (USD)
Plasmid 113665 Standard format: Plasmid sent in bacteria as agar stab 1 $75

This material is available to academics and nonprofits only.

Backbone

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    Emicizumab anti-FX/FXa heavy chain
  • Species
    humanized monoclonal antibody
  • Promoter CMV Promoter

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site NheI (not destroyed)
  • 3′ cloning site NotI (not destroyed)
  • 5′ sequencing primer T7 Promoter
  • (Common Sequencing Primers)

Resource Information

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    anti-FX(a) Emi HC was a gift from Robert Peters (Addgene plasmid # 113665 ; http://n2t.net/addgene:113665 ; RRID:Addgene_113665)
  • For your References section:

    Intrinsic differences between FVIIIa mimetic bispecific antibodies and FVIII prevent assignment of FVIII-equivalence. Leksa NC, Aleman MM, Goodman A, Rabinovich D, Peters R, Salas J. J Thromb Haemost. 2019 Mar 18. doi: 10.1111/jth.14430. 10.1111/jth.14430 PubMed 30887655